ATHX is the leader in ReGMed using Adult Stem Cells.
the CEO/Gil is the MOST respected CEO/researcher in the industry.
Its off the shelf multistem platform is worth "Trillions" not "Billions".
With the new equity investor ATHX will be looking at a a 50% institutional ownership with a PALTRY 23million outstanding share.
IMO ATHX will never "stay together" Pfiezer will buy this company for 20billion...Hopefully not, as you said $300.00 is a reality and not just wishful thinking.
I called ATHX a buy on 11/23/2011.
sf
Disclosure: I own 19,000 shares @ an average of $1.25 and I will sell themm IMO in 2014 for 100.00 a share...